Category: Interviews

NOVOS is a nutraceutical company focused on developing science-based nutraceuticals to slow down aging and will offer tests to track people’s aging processes to get a better picture of their health. The company offers two nutraceutical products, NOVOS Core and NOVOS Boost. Core contains 12 ingredients that the company believes can slow down aging. Boost...

Tina Woods is a UK-based founder of several social enterprises in healthcare and longevity and the author of the book Live Longer with AI, which we recently reviewed. In this interview, Tina shares valuable insights on how social entrepreneurship works in our field, what governments can and must do to promote healthy aging, and what...

We interviewed a group of Russian biohackers who performed a plasma dilution experiment on themselves. This experiment, the first of its kind, was based on previous mouse studies by Drs. Irina and Michael Conboy. Some molecules, while essential for various body functions, can be harmful when overproduced. Inflammatory cytokines, such as transforming growth factor beta...

Today, we want to spotlight NOVOS, a nutraceutical company that is focused on developing science-based nutraceuticals to slow down aging and that will offer tests to track people's aging processes and get a better picture of their health. The company is launching two new supplements: NOVOS Core and NOVOS Boost. NOVOS claims that its nutraceuticals:...

Today, we are interviewing Breanna Deutsch, a policy expert and the author of Finding the Fountain, which we have previously reviewed. Breanna comes from the world of political communications, and she explains what needs to be done to encourage policymakers to pave the way for a world of rejuvenation. How did you get into the...

In this interview at Ending Age-Related Diseases 2020, Keith Comito interviews Ronald Kohanski of the National Institute of Aging about this government agency's systemic approach to extending healthspan, the time during which a person enjoys a healthy life free of age-related diseases. He explains what his agency does to aid the development of therapies against aging, including public-private partnerships and grants for researchers.